Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1562 to 1611 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1562\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine aminotransferase (ec 2.6.1.5) (l-tyrosine:2-oxoglutarate aminotransferase) (tat). [source:swissprot;acc:p17735]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
167.687\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
170.455\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01651\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1563\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp synthase gamma chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p36542]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.277\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
214.739\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01648\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1564\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp synthase oligomycin sensitivity conferral protein, mitochondrial precursor (ec 3.6.3.14) (oscp). [source:swissprot;acc:p48047]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1565\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 11 (eif-3 p25) (eif3k) (muscle specific gene m9 protein) (ptd001) (hspc029) (arg134). [source:swissprot;acc:q9ubq5]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
221.128\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
224.767\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01646\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1566\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
erythroid differentiation and denucleation factor 1. [source:swissprot;acc:o60584]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1567\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bardet-biedl syndrome 7 protein isoform a; bbs2-like 1. [source:refseq;acc:nm\_176824]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1568\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba508n22.1 (hspc025) (fragment). [source:sptrembl;acc:q9hcw5]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1569\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lipopolysaccharide-responsive and beige-like anchor protein (cdc4-like protein) (beige-like protein). [source:swissprot;acc:p50851]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1570\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein c20orf45 (cgi-107). [source:swissprot;acc:q9y3b1]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1571\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 6 interacting protein (hspc021/hspc025). [source:swissprot;acc:q9y262]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1572\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative rna-binding protein 7 (rna binding motif protein 7). [source:swissprot;acc:q9y580]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1573\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
r3h domain protein 1. [source:swissprot;acc:q15032]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.105\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.573\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1574\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tata element modulatory factor (tmf). [source:swissprot;acc:p82094]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
222.585\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.982\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01645\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1575\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
scy1-like 1; telomerase regulation-associated protein; ht019 protein; telomerase regulation-associated protein; n-terminal kinase-like protein; teratoma-associated tyrosine kinase; n-terminal kinase-like. [source:refseq;acc:nm\_020680]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1576\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear pore complex protein nup98 (nucleoporin nup98) (98 kda nucleoporin). [source:swissprot;acc:p52948]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1577\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ammecr1 protein. [source:refseq;acc:nm\_015365]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1578\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mrna-associated protein mrnp 41 (rae1 protein homolog). [source:swissprot;acc:p78406]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1579\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cda11 protein. [source:refseq;acc:nm\_032026]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.181\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.732\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01644\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1580\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
g2/mitotic-specific cyclin b2. [source:swissprot;acc:o95067]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
168.018\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
170.769\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01637\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1581\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division protein kinase 3 (ec 2.7.1.-). [source:swissprot;acc:q00526]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
168.002\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
170.753\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1582\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
g2/mitotic-specific cyclin b1. [source:swissprot;acc:p14635]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
168.098\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
170.844\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01634\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1583\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division protein kinase 2 (ec 2.7.1.-) (p33 protein kinase). [source:swissprot;acc:p24941]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
168.091\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
170.837\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1584\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphogluconolactonase (ec 3.1.1.31) (6pgl). [source:swissprot;acc:o95336]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.891\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.432\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01633\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1585\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division control protein 2 homolog (ec 2.7.1.-) (p34 protein kinase) (cyclin-dependent kinase 1) (cdk1). [source:swissprot;acc:p06493]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
168.145\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
170.888\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01631\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1586\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 1 beta 1 subunit (beta-adaptin 1) (adaptor protein complex ap-1 beta-1 subunit) (golgi adaptor ha1/ap1 adaptin beta subunit) (clathrin assembly protein complex 1 beta large chain). [source:swissprot;acc:q10567]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
222.166\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.79\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1587\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein c20orf4 (protein cgi-23) (pro0225). [source:swissprot;acc:q9y312]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.129\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.598\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0163\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1588\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ring finger protein 25 (ec 6.3.2.-). [source:swissprot;acc:q96bh1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
177.834\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
180.725\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01626\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1589\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
valyl-trna synthetase 2 (ec 6.1.1.9) (valine--trna ligase 2) (valrs 2) (g7a). [source:swissprot;acc:p26640]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
223.589\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.219\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01624\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1590\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
thymidylate synthase (ec 2.1.1.45) (ts) (tsase). [source:swissprot;acc:p04818]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
225.119\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
228.769\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01621\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1591\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dihydrofolate reductase (ec 1.5.1.3). [source:swissprot;acc:p00374]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1592\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
stromal cell-derived factor 2 precursor (sdf-2). [source:swissprot;acc:q99470]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1593\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
stromal cell-derived factor 2-like protein 1 precursor (sdf2 like protein 1) (pwp1-interacting protein 8). [source:swissprot;acc:q9hcn8]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1594\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 1 gamma 2 subunit (gamma2-adaptin) (adaptor protein complex ap-1 gamma-2 subunit) (g2ad). [source:swissprot;acc:o75843]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
222.133\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
225.731\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0162\vspace{3pt}}\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1595\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 1 sigma 1b subunit (sigma-adaptin 1b) (adaptor protein complex ap-1 sigma-1b subunit) (golgi adaptor ha1/ap1 adaptin sigma-1b subunit) (clathrin assembly protein complex 1 sigma- 1b small chain) (sigma 1b subunit of ap-1 clathrin) (dc22). [source:swissprot;acc:p56377]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
222.134\vspace{3pt}}}&&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01619\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1596\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 1 gamma 1 subunit (gamma-adaptin) (adaptor protein complex ap-1 gamma-1 subunit) (golgi adaptor ha1/ap1 adaptin gamma-1 subunit) (clathrin assembly protein complex 1 gamma-1 large chain). [source:swissprot;acc:o43747]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1597\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 1 sigma 1c subunit (sigma-adaptin 1c) (adaptor protein complex ap-1 sigma-1c subunit) (golgi adaptor ha1/ap1 adaptin sigma-1c subunit) (clathrin assembly protein complex 1 sigma- 1c small chain) (sigma 1c subunit of ap-1 clathrin). [source:swissprot;acc:q96pc3]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1598\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 1 sigma 1a subunit (sigma-adaptin 1a) (adaptor protein complex ap-1 sigma-1a subunit) (golgi adaptor ha1/ap1 adaptin sigma-1a subunit) (clathrin assembly protein complex 1 sigma- 1a small chain) (clathrin coat assembly protein ap19) (ha1 19 kda subunit) (sigma 1a subunit of ap-1 clathrin). [source:swissprot;acc:q00382]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1599\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dystrobrevin binding protein 1; dysbindin. [source:refseq;acc:nm\_032122]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.871\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.404\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01617\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1600\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 2 beta 1 subunit (beta-adaptin) (plasma membrane adaptor ha2/ap2 adaptin beta subunit) (clathrin assembly protein complex 2 beta large chain) (ap105b). [source:swissprot;acc:p21851]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
222.103\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.675\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01608\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1601\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphomannomutase 2 (ec 5.4.2.8) (pmm 2). [source:swissprot;acc:o15305]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.268\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.842\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01602\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1602\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphomannomutase 1 (ec 5.4.2.8) (pmm 1) (pmmh-22). [source:swissprot;acc:q92871]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.334\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.914\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01599\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1603\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock factor binding protein 1. [source:swissprot;acc:o75506]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01595\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1604\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase clk2 (ec 2.7.1.-) (cdc-like kinase 2). [source:swissprot;acc:p49760]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.984\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.614\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01593\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1605\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocyte nuclear factor 3-alpha (hnf-3a) (forkhead box protein a1). [source:swissprot;acc:p55317]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.322\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.916\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01592\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1606\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
apolipoprotein a-i binding protein; apoa-i binding protein. [source:refseq;acc:nm\_144772]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.916\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.662\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0159\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1607\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase clk3 (ec 2.7.1.-) (cdc-like kinase 3). [source:swissprot;acc:p49761]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.982\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.622\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01588\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1608\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 variant 1 isoform b; dna-binding protein. [source:refseq;acc:nm\_003349]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208.106\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.867\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01581\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1609\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
utp--glucose-1-phosphate uridylyltransferase 2 (ec 2.7.7.9) (udp- glucose pyrophosphorylase 2) (udpgp 2) (ugpase 2). [source:swissprot;acc:q16851]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208.113\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.876\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0158\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1610\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 variant 2; 1 alpha,25-dihydroxyvitamin d3-inducible; enterocyte differentiation promoting factor; methyl methanesulfonate sensitive 2, s. cerevisiae, homolog of. [source:refseq;acc:nm\_003350]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208.122\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.886\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01579\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1611\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
p10-binding protein. [source:refseq;acc:nm\_024491]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.313\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.877\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01577\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/